江苏快乐十分

On October 12, 2015, after fierce competition Ustar Biotechnology （Hangzhou）Co., Ltd. won the third place in the group of bio-pharmaceutical industry enterprises in the fourth National Innovation Contest. On November 29, 2016 Ustar received the fourth National Innovation Competition winners’ prize (500,000 yuan).

江苏快乐十分    Bill & Melinda Gates Foundation decided to provide free research funding and investments totaling $ 11.27 million for research and development of second-generation detection products (CPA automated nucleic acid diagnostic reagents and analyzers) to Ustar Biotechnologies in November 2014. The first phase fund was put in place in November 2014.

江苏快乐十分    After unremitting efforts of R&D and other teams, the research and development of the second-generation products "CPA automated nucleic acid diagnostic reagents and analyzers” is progressing well.  The mid-term project review was approved by the Gates Foundation on August 4, 2016.  Ustar received the second phase research fund (about US $ 1.74 million) from Gates Foundation on September 15, 2016.

江苏快乐十分Two of China's top health innovators held the spotlight at the recent Grand Challenges Initiative anniversary meeting, a grant competition set up by the Bill and Melinda Gates Foundation, earlier this month. 

江苏快乐十分The grant organization, aiming to solve key health problems for the poor through innovation and technology, honored You Qimin during the 10th Grand Challenges Anniversary on Wednesday. 

"I feel that the whole world is embracing me," You said on the last day of the meeting, held from Oct.6 to Oct.8 in Seattle. He was among more than 1,000 participators from 47 countries attending the anniversary.

江苏快乐十分Earlier this year, You, the CEO of  Hangzhou-based Ustar Biotechnologies, was funded 11.27 million U.S. dollars from the Gates Foundation. 

The company had received a grant from the Grand Challenges Canada in October 2011 to develop and market an innovative, portable, low-cost and rapid nucleic acid test for HIV and TB(tuberculosis). It is the first Chinese company to receive such funding.